European Journal of Chemistry 2017, 8(1), 1-7 | doi: https://doi.org/10.5155/eurjchem.8.1.1-7.1512 | Get rights and content

Issue cover





  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole


Zarife Sibel Şahin (1,*) , Mine Yarım (2) , Meriç Köksal (3)

(1) Sinop University, Faculty of Engineering and Architectures, Department of Energy Systems Engineering, 57000, Sinop, Turkey
(2) Yeditepe University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34755, Kayışdağı, İstanbul, Turkey
(3) Yeditepe University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34755, Kayışdağı, İstanbul, Turkey
(*) Corresponding Author

Received: 01 Dec 2016 | Revised: 22 Dec 2016 | Accepted: 25 Dec 2016 | Published: 31 Mar 2017 | Issue Date: March 2017

Abstract


The crystal and molecular structure of 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole (I) has been determined by single-crystal X-ray diffraction. Molecular geometry of compound I in the ground state has been calculated using the density functional method (DFT) with B3LYP/6-31G(d,p) basis set and compared with the experimental data. In addition, density functional calculations of the structure, molecular electrostatic potential map, frontier molecular orbitals, atomic charges, thermodynamic functions and global chemical reactivity descriptors of compound I were performed.


Announcements


One of our sponsors will cover the article processing fee for all submissions made between May 17, 2023 and June 16, 2023 (Voucher code: SPONSOR2023).

Editor-in-Chief
European Journal of Chemistry

Keywords


Indole; Piperazine; DFT calculations; Crystal structure; Frontier molecular orbitals; Molecular electrostatic potential map

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.8.1.1-7.1512

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 1172 times | icon graph PDF Article downloaded 439 times


Citations

/


[1]. Piotr Stępnicki, Olga Wronikowska-Denysiuk, Agata Zięba, Katarzyna M. Targowska-Duda, Agata Bartyzel, Martyna Z. Wróbel, Tomasz M. Wróbel, Klaudia Szałaj, Andrzej Chodkowski, Karolina Mirecka, Barbara Budzyńska, Emilia Fornal, Jadwiga Turło, Marián Castro, Agnieszka A. Kaczor
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation
Journal of Enzyme Inhibition and Medicinal Chemistry  38(1), , 2023
DOI: 10.1080/14756366.2023.2209828
/


[2]. Piotr Stępnicki, Katarzyna M. Targowska-Duda, Antón L. Martínez, Agata Zięba, Olga Wronikowska-Denysiuk, Martyna Z. Wróbel, Agata Bartyzel, Alicja Trzpil, Tomasz M. Wróbel, Andrzej Chodkowski, Karolina Mirecka, Tadeusz Karcz, Katarzyna Szczepańska, Maria I. Loza, Barbara Budzyńska, Jadwiga Turło, Jadwiga Handzlik, Emilia Fornal, Ewa Poleszak, Marián Castro, Agnieszka A. Kaczor
Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling
European Journal of Medicinal Chemistry  252, 115285, 2023
DOI: 10.1016/j.ejmech.2023.115285
/


[3]. Li-Yan Zeng, Fubiao Yang, Kaixuan Chen, Yunong Zeng, Zhenzhou Jiang, Shuwen Liu, Baomin Xi
The one-pot synthesis of butyl-1H-indol-3-alkylcarboxylic acid derivatives in ionic liquid as potent dual-acting agent for management of BPH
European Journal of Medicinal Chemistry  205, 112616, 2020
DOI: 10.1016/j.ejmech.2020.112616
/


References


[1]. Aydar, E.; Palmer, C. P.; Klyachko, V. A.; Jackson, M. B. Neuron 2002, 34, 399-410.
https://doi.org/10.1016/S0896-6273(02)00677-3

[2]. Jbilo, O.; Vidal, H.; Paul, R.; Nys, N. D.; Bensaid, M.; Silve, S.; Carayon, P.; Davi, D.; Galiegue, S.; Bourrie, B.; Guillemot, J. C.; Ferrara, P.; Loison, G.; Maffrand, J. P.; Le Fur, G.; Casellas, P. J. Biol. Chem. 1997, 272, 27107-27115.
https://doi.org/10.1074/jbc.272.43.27107

[3]. Hanner, M.; Moebius, F. F.; Flandorfer, A. A.; Knaus, H. G.; Striessnig, J.; Kempner, E.; Glossmann, H. Proc. Natl. Acad. Sci. USA 1996, 93, 8072-8077.
https://doi.org/10.1073/pnas.93.15.8072

[4]. Mei, J. F.; Pasternak, G. W. Biochem. Pharmacol 2001, 62, 349-355.
https://doi.org/10.1016/S0006-2952(01)00666-9

[5]. Pan, Y. X.; Mei, J.; Xu, J.; Wan, B. L.; Zuckerman, A.; Pasternak, G. W. J. Neurochem. 1998, 70, 2279-2285.
https://doi.org/10.1046/j.1471-4159.1998.70062279.x

[6]. Seth, P.; Leibach, F. H.; Ganapathy, V. Biochem. Biophys. Res. Commun 1997, 241, 535-540.
https://doi.org/10.1006/bbrc.1997.7840

[7]. Seth, P.; Fei, Y. J.; Li, H. W.; Huang, W.; Leibach, F. H.; Ganapathy, V. J. Neurochem. 1998, 70, 922-931.
https://doi.org/10.1046/j.1471-4159.1998.70030922.x

[8]. Abou-Gharbia, M.; Ablordeppey, S. Y.; Glennon, R. Ann Rep Med Chem. 1993, 28, 1-10.
https://doi.org/10.1016/S0065-7743(08)60871-4

[9]. Hayashi, T.; Su, T. P. CNS Drugs 2004, 18, 269-284.
https://doi.org/10.2165/00023210-200418050-00001

[10]. Sorbera, L. A.; Silvestre, J.; Castaner, J. Drugs Fut. 1999, 24, 133-140.
https://doi.org/10.1358/dof.1999.024.02.474038

[11]. Foster, A.; Wu, H.; Chen, W.; Williams, W.; Bowen, W. D.; Matsumoto, R. R. A. Coop, Bioorg. Med. Chem. Lett. 2003, 13, 749-751.
https://doi.org/10.1016/S0960-894X(02)01034-X

[12]. Matsumoto, R. R.; Liu, Y.; Lerner, M.; Howard, E. W.; Bracket, D. J. Eur. J. Pharmacol. 2003, 469, 1-12.
https://doi.org/10.1016/S0014-2999(03)01723-0

[13]. Matsumoto, R. R.; McCracken, K. A.; Pouw, B.; Miller, J.; Bowen, W. D.; Williams, W.; deCosta, B. R. Eur. J. Pharmacol. 2001, 411, 261-273.
https://doi.org/10.1016/S0014-2999(00)00917-1

[14]. Crawford, K. W.; Bowen, W. D. Cancer Res. 2002, 62, 313-322.

[15]. Spruce, B. A.; Campbell, L. A.; McTavish, N.; Cooper, M. A.; Appleyard, V. L.; O'Neill, M.; Howie, J.; Samson, J.; Watt, S.; Murray, K.; McLean, D.; Leslie, N. R.; Safrany, S. T.; Ferguson, M. R.; Peters, J. A.; Prescott, A. R.; Box, G.; Hayes, A.; Nutley, B.; Raynaud, F.; Downes, C. P.; Lambert, J. J.; Thompson, A. M.; Eccles, S. Cancer Res. 2004, 64, 4875-4886.
https://doi.org/10.1158/0008-5472.CAN-03-3180

[16]. Choi, S. R.; Yang, B.; Plossl, K.; Chumpradit, S.; Wey, S. P.; Acton, P. D.; Wheeler, K.; Mach, R. H.; Kung H. F. Nucl. Med. Biol. 2001, 28, 657-666.
https://doi.org/10.1016/S0969-8051(01)00234-7

[17]. John, C. S.; Lim, B. B.; Vilner, B. J.; Geyer, B. C.; Bowen, W. D. J. Med. Chem. 1998, 41, 2445-2450.
https://doi.org/10.1021/jm9800447

[18]. Lipkowitz, K. B.; Boyd, D. Reviews in Computational Chemistry, Eds.; VCH: New York, Vols. 1-13, 1990-1999.

[19]. Zhang, Y.; Guo, A. J.; You, X. Z. J Am Chem Soc. 2001, 123, 9378-9387.
https://doi.org/10.1021/ja0023938

[20]. Yarim, M.; Koksal, M.; Schepmann, D.; Wünsch, B. Chem Biol Drug Des. 2011, 78(5), 869-875.
https://doi.org/10.1111/j.1747-0285.2011.01215.x

[21]. Sheldrick, G. M. Acta Cryst. A 2008, 64, 112-122.
https://doi.org/10.1107/S0108767307043930

[22]. Farrugia, L. J. WINGX-A Windows Program for Crystal Structure Analysis, University of Glasgow, 1998.

[23]. Farrugia, L. J. J. Appl Crystallogr. 1999, 30, 837-838.
https://doi.org/10.1107/S0021889899006020

[24]. Mercury, version 3. 0; CCDC, available online via ccdc. cam. ac. uk/products/mercury.

[25]. Spek, A. L. PLATON-A Multipurpose Crystallographic Tool, Utrecht, Utrecht University, The Netherlands, 2005.

[26]. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Jr. Montgomery, J. A.; Vreven, J. T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski J. W.; Ayala P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Lui, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W. B.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. GAUSSIAN 03, Revision C. 02, Gaussian Inc, Wallingford CT., 2004.

[27]. Frisch, A.; Dennington II, R. D.; Keith, T. A.; Milliam, J.; Nielsen, A. B.; Holder, A. J.; Hiscocks, J. GaussView Reference, Version 4. 0. Gaussian Inc., Pittsburgh, 2007.

[28]. Hohenberg, P.; Kohn, W. Phys. Rev. B 1964, 136, 846-864.

[29]. Kohn, W.; Sham, L. J. Phys. Rev. A 1965, 140, 1133-1138.
https://doi.org/10.1103/PhysRev.140.A1133

[30]. Peng, C.; Ayala, P. Y.; Schlegel, H. B.; Frisch, M. J. J Comput Chem. 1996, 17, 43-49.
https://doi.org/10.1002/(SICI)1096-987X(19960115)17:1<49::AID-JCC5>3.0.CO;2-0

[31]. Stephens, P. J.; Devlin, F. J.; Chablowski, C. F.; Frisch, M. J. J Phys Chem. 1994, 98, 11623-11627.
https://doi.org/10.1021/j100096a001

[32]. Cremer, D.; Pople, J. A. J. Am. Chem. Soc. 1975, 97, 1354-1358.
https://doi.org/10.1021/ja00839a011

[33]. Sahin, Z. S.; Isık, S.; Salgın-Goksen, U.; Gokhan-Kelekci, N. Chinese J. Struct. Chem. 2010, 29, 700-705.

[34]. Sahin, Z. S.; Ozkan, I.; Koksal, M.; Isık, S. J. Struct. Chem. 2012, 53, 938-941.
https://doi.org/10.1134/S0022476612050162

[35]. Li, Y.; Sun, H.; Jiang, H.; Xu, N.; Xu, H. Acta Cryst. E 2014, 70, 259-261.
https://doi.org/10.1107/S1600536814020686

[36]. Bernstein, J.; Davis, R. E.; Shimoni, L.; Chang, N. L. Angew. Chem. Int. Ed. Engl. 1995, 34, 1555-1573.
https://doi.org/10.1002/anie.199515551

[37]. Leach, A. R. Molecular modelling-Principles and applications, Prentice Hall, 2nd edn, Harlow, 2001.

[38]. Jensen, F. Introduction to computational chemistry, Wiley: 2nd ed. Chichester, UK, 2006.

[39]. Aihara, J. J. Phys. Chem. A 1999, 103, 7487-7495.
https://doi.org/10.1021/jp990092i

[40]. Politzer, P.; Daiker, K. C. Models for Chemical Reactivity. In The Force Concept in Chemisty Van Nostrand Reinhold New York, 1981.

[41]. Cox, S. R.; Williams, D. E. J. Compt. Chem. 1981, 2, 304-323.
https://doi.org/10.1002/jcc.540020312

[42]. Carbo, R.; Calabuig, B. Compt. Phys. Commun. 1989, 55, 117-126.
https://doi.org/10.1016/0010-4655(89)90070-2

[43]. Politzer, P.; Truhlar, D. G. In: Chemical Applications of Atomic and Molecular Electrostatic Potentials Plenum, New York, 1981.
https://doi.org/10.1007/978-1-4757-9634-6

[44]. Scrocco, E.; Tomasi, J. Top. Curr. Chem. 1973, 42, 69-95.

[45]. Sahin, Z. S.; Salgin-Goksen, U.; Gokhan-Kelekci, N.; Isik, S. J. Mol. Struct. 2011, 1006, 147-158.
https://doi.org/10.1016/j.molstruc.2011.08.061

[46]. McQuarrie, D. A. Molecular Thermodynamics, Calif., University Science Books, Sausalito, 1999.

[47]. Hehre, W. J. AB initio Molecular Orbital Theory, Wiley: New York, 1986.

[48]. Li, X. W.; Shibata, E.; Nakamura, T. Materials Trans. 2003, 44-5, 1004-1007.
https://doi.org/10.2320/matertrans.44.1004

[49]. Merrick, J. P.; Moran, D.; Radom, L. J. Phys. Chem. A 2007, 111, 11683-11700.
https://doi.org/10.1021/jp073974n

[50]. Sahin, Z. S.; Kaya-Kantar, G.; Sasmaz, S.; Buyukgungor, O. J. Mol. Struct. 2015, 1087, 104-112.
https://doi.org/10.1016/j.molstruc.2015.01.039


Supporting information


The Supplementary Material for this article can be found online at: Supplementary files

How to cite


Şahin, Z.; Yarım, M.; Köksal, M. Eur. J. Chem. 2017, 8(1), 1-7. doi:10.5155/eurjchem.8.1.1-7.1512
Şahin, Z.; Yarım, M.; Köksal, M. Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole. Eur. J. Chem. 2017, 8(1), 1-7. doi:10.5155/eurjchem.8.1.1-7.1512
Şahin, Z., Yarım, M., & Köksal, M. (2017). Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole. European Journal of Chemistry, 8(1), 1-7. doi:10.5155/eurjchem.8.1.1-7.1512
Şahin, Zarife, Mine Yarım, & Meriç Köksal. "Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole." European Journal of Chemistry [Online], 8.1 (2017): 1-7. Web. 3 Jun. 2023
Şahin, Zarife, Yarım, Mine, AND Köksal, Meriç. "Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole" European Journal of Chemistry [Online], Volume 8 Number 1 (31 March 2017)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.8.1.1-7.1512


CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2017, 8(1), 1-7 | doi: https://doi.org/10.5155/eurjchem.8.1.1-7.1512 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)





© Copyright 2010 - 2023  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.